cmClaudia Mitchell is the the CEO and co-founder of Universal Cells Inc. Claudia has previously co-founded Halo-Bio RNAi Therapeutics, a Seattle-based biotech start-up company developing new RNAi molecules, and served as its Chief Scientific Officer from 2008 to 2011. Besides being a biotech entrepreneur, Claudia has also held positions in the non-profit sector and in Academia. She worked as the Program Director at the LGMD2I Research Fund, a family non-profit foundation, and has held a tenured Academic research position at the French National Institute of Medical Research (INSERM). She received her PhD in Molecular Biology from the University of Paris and an MBA in International Management from the Ecole des Ponts Business School, Paris, France.

“Business & Innovation in Health: Breath-Taking Breakthroughs in Invention and Implementation” Thursday Luncheon May 4th